Accendra Health

Direct pricing power is constrained by Medicare, Medicaid and commercial payer schedules. Margin improvement typically comes from mix, documentation rigor, resupply adherence and operations rather than list price increases. The company’s own disclosures emphasize reimbursement dependency and competitive bidding risk across DMEPOS categories.

We see limited latent pricing power beyond what mix and productivity can yield.